Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLL
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Takara Bio Inc.
Related studies linked through entity extraction aliases.